Makers Laboratories Q1 FY27 Results: Revenue Rs 42 Cr, PAT Rs 4.00 Cr and Key Highlights
- August 11, 2026
- Posted by: Kunal Singla
- Category: News
Makers Laboratories Q1 FY27 results declared August 7, 2026. Revenue Rs 42 Cr (+22.20% YoY). PAT Rs 4.00 Cr (+257.39% YoY). CMP Rs 158.95 (-4.19%).
Makers Laboratories Q1 FY27 results were declared on August 7, 2026 on a consolidated basis. Revenue expanded +22.20% YoY to Rs 42 Cr from Rs 35 Cr in Q1 FY26. The broader Nifty Pharma index reflected mixed sentiment during the quarter.
Operating profit in Makers Laboratories Q1 FY27 results stood at Rs 5.00 Cr (+208.54% YoY). PAT was Rs 4.00 Cr (+257.39% YoY), highlighting the key financial metrics investors are tracking for Makers Laboratories Q1 FY27 results.
Click Here – Get Free Investment Predictions
Makers Laboratories Q1 FY27 Financial Highlights
| Metric | Q1 FY27 (Rs Cr) | Q1 FY26 (Rs Cr) | YoY Change |
|---|---|---|---|
| Makers Laboratories Revenue | 42 | 35 | +22.20% |
| Operating Profit | 5.00 | 1.00 | +208.54% |
| Net Profit (PAT) | 4.00 | 1.00 | +257.39% |
| Reporting Basis | Consolidated | ||
Makers Laboratories Q1 FY27 Performance Analysis
Check the Univest Screener for Live Data on This Stock
Makers Laboratories Q1 FY27 results reflect exceptional fundamentals. Revenue growth momentum were evident with the top line at Rs 42 Cr for the April to June 2026 quarter.
Operating profit improved +208.54% YoY. Better cost absorption supported the operating performance. PAT of Rs 4.00 Cr reflects +257.39% YoY movement in Makers Laboratories Q1 FY27 results.
Investors monitoring Makers Laboratories Q1 FY27 results will note these numbers as key milestones for the FY27 earnings trajectory and sector positioning.
Key Business Factors in Makers Laboratories Q1 FY27 Results
Revenue Trend in Q1 FY27
Makers Laboratories Q1 FY27 results show revenue expanding +22.20% YoY to Rs 42 Cr from Rs 35 Cr in Q1 FY26. Volume-led growth and market share gains supported the top-line trajectory.
Operating Profit Performance
Operating profit in Makers Laboratories Q1 FY27 results stood at Rs 5.00 Cr (+208.54% YoY). Improved cost control and product mix contributed to the operating performance.
PAT and Profitability in Q1 FY27
PAT in Makers Laboratories Q1 FY27 results stood at Rs 4.00 Cr (+257.39% YoY). The company is focused on sustaining profitability through operational efficiencies.
Dividend Details
No dividend was declared alongside Makers Laboratories Q1 FY27 results. Earnings are being channelled toward operational needs and working capital.
FY27 Outlook for Makers Laboratories
Makers Laboratories is focused on sustaining its financial trajectory through FY27 via operational improvements and market expansion in the pharmaceuticals segment. Investors tracking Makers Laboratories Q1 FY27 results should consult a SEBI-registered financial advisor before making decisions.
Makers Laboratories Stock Performance After Q1 FY27 Results
Download the Univest iOS App or Univest Android App to track Makers Laboratories live price and get daily stock recommendations.
Makers Laboratories shares were trading lower at Rs 158.95 (-4.19%) on August 7, 2026, reflecting market sentiment on Makers Laboratories Q1 FY27 results. The stock reaction reflects broader investor sentiment toward the pharmaceuticals space.
Key Risks for Makers Laboratories
Sector-Specific Risks
USFDA regulatory risks, pricing pressure in generics, and API cost inflation.
Valuation and Earnings Risk
Valuation risk remains if quarterly growth momentum fails to sustain over the next two to three quarters.
Operational and Financial Risk
Subsidiary-level underperformance could drag consolidated earnings lower in subsequent quarters.
Conclusion
Makers Laboratories Q1 FY27 results reflect exceptional performance with revenue at Rs 42 Cr and PAT at Rs 4.00 Cr on a Consolidated basis. The FY27 growth trajectory will depend on operational execution and sector demand recovery. Investors should review management commentary before taking any position.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Makers Laboratories Q1 FY27 Results
When were Makers Laboratories Q1 FY27 results declared?
Ans. Makers Laboratories Q1 FY27 results were declared on August 7, 2026, covering the April–June 2026 quarter on a Consolidated basis.
What was Makers Laboratories revenue in Q1 FY27?
Ans. Revenue in Makers Laboratories Q1 FY27 results was Rs 42 Cr, +22.20% YoY from Rs 35 Cr in Q1 FY26.
What was Makers Laboratories PAT in Q1 FY27?
Ans. Net profit in Makers Laboratories Q1 FY27 results was Rs 4.00 Cr (+257.39% YoY).
Did Makers Laboratories declare a dividend in Q1 FY27?
Ans. No dividend was announced with Makers Laboratories Q1 FY27 results. Check official NSE and BSE announcements for updates.
What is the FY27 outlook for Makers Laboratories?
Ans. Management is focused on sustained growth and margin improvement through FY27. Sector trends will be key monitorables.
How did Makers Laboratories stock perform after Q1 FY27 results?
Ans. Makers Laboratories shares were lower at Rs 158.95 (-4.19%) on August 7, 2026. Consult a SEBI-registered advisor before acting on price movements.
